Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open label, repeat dose, dose escalation study conducted in Parkinson's disease patients to characterize the pharmacokinetics and effect of food on ropinirole prolonged release (PR/CR [controlled release]) 12mg tablets

Trial Profile

An open label, repeat dose, dose escalation study conducted in Parkinson's disease patients to characterize the pharmacokinetics and effect of food on ropinirole prolonged release (PR/CR [controlled release]) 12mg tablets

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Nov 2016

At a glance

  • Drugs Ropinirole (Primary)
  • Indications Parkinson's disease
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 08 Nov 2007 Status changed from initiated to completed.
    • 21 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top